Sinoway Industrial Co.,Ltd is a famous China liraglutide manufacturer and supplier, welcome to buy GMP and EP liraglutide from us and check the price with us. 1.Product Description: 1.Product NameLiraglutide 2.Appereance:White to off-white crystalline powder 3.Molecular Formula C172H265N43O51...Send Inquiry
2.Appereance:White to off-white crystalline powder
3.Molecular Formula C172H265N43O51
4.Cas. No. 204656-20-2
5.Molecular Weight 3751.20
Liraglutide(NN2211) is a long-actingglucagon-like peptide-1 receptor agonist, binding to the same receptors as does theendogenousmetabolichormoneGLP-1that stimulatesinsulinsecretion.
White to off-white crystalline powder or lumps
Purity (By HPLC) :
Not Less than 98.0%;
Total Impurity ≤ 2.0%
Largest Single Impurity ≤ 1.0%
Not Less than 85.0%
Not more than 5%
Not more than 10%
Not more than 50IU/mg
4.Function and Usage:
Type 2 diabetes
Liraglutide improves control ofblood glucose.It reduces meal-relatedhyperglycemia(for 24 hours after administration) by increasinginsulinsecretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandialglucagonsecretion.
In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over more traditional therapies for type 2 diabetes:
1).It acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk ofhypoglycemia.
2).It has the potential for inhibitingapoptosisand stimulating regeneration ofbeta cells(seen in animal studies).
3).It decreases appetite and inhibits body weight gain, as shown in a head-to-head study versusglimepiride.
4).It lowers bloodtriglyceridelevels.
Liraglutide has been approved as an injectable adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients. The specified criteria are an initial body mass index (BMI) of 30kg/m2 or greater (obese), or 27kg/m2 or greater (overweight), in the presence of at least one weight-related comorbid condition (e.g.hypertension, type 2 diabetes mellitus, or dyslipidemia). In late 2014, data were reported from the SCALE™ Obesity and Prediabetes trial,which is a randomised, double-blind, placebo-controlled, multinational trial in non-diabetic people with obesity and non-diabetic people who are overweight with comorbidities. In this phase 3a trial, there were 3,731 participants randomised to treatment with liraglutide 3mg or placebo, both in combination with diet and exercise. Those who completed the 56-week trial achieved an average weight loss of 9.2%, to be compared with a 3.5% reduction in the placebo group.
More details pls contact me :
Ms. Serein Yan
International Sales Department
Sinoway Industrial Co., Ltd. (29 years, ISO9001:2008 and SGS certified)
Add: 16/F., Huicheng Comm. Complex, No.839 Xiahe Rd, Xiamen, China (Postal Code: 361004)
Tel: 0086-592-5887162 Fax: 0086-592-5854960
Skype: serein95 , Mobile/ Wechat / Whats App: 0086-15060741657
Specializing in the research, development and custom manufacturing of hot sale liraglutide powder ,cas:204656-20-2, SINOWAY, though situated in China, enjoys good reputation among international customers. We supply you with pure natural and well extracted products which can give the best care.